Pulse Biosciences, Inc. planned insider sales
In the last twelve months insiders at Pulse Biosciences, Inc. filed 2 Form 144 notices of planned sales, 125,000 shares worth $2.8 million at the time of filing, from 1 seller. The latest, filed 12 February 2026: Kevin Danahy (officer), 50,000 shares worth $1.3 million, planned for around 12 February 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Sold, per Form 4 | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 12 February 2026 | Kevin Danahy | Officer | 50,000 | $1.3 million | 12 February 2026 | 85,000 shares from 11 February 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
| 9 February 2026 | Kevin Danahy | Officer | 75,000 | $1.6 million | 9 February 2026 | 40,000 shares from 9 February 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.